06.12.2022
Cell Therapy Manufacturing and Gene Therapy Congress 2022

Glycostem is going to present at the Cell Therapy Manufacturing and Gene Therapy Congress 2022 in Amsterdam.

6 Dec 2022, 11:35 (CET)

Scaling to Commercial Scale: Cord Blood Stem Cell Derived NK Cells

- presented by John Veluchamy, Senior Development Scientist

6 Dec 2022, 15:00 (CET)

Quality by Design for Cell Therapy Manufacturing

- presented by Valters Stelmanis, Regulatory Specialist


 

 

23.11.2022
European Immuno-Oncology Xchange

Glycostem CDO Volker Huppert is going to participate and lead a discussion at European Immuno-Oncology Xchange 2022 roundtable meeting on 23rd November 2022 in Zurich, Switzerland.

Topic: Cell Therapies going off-the-shelf: non-modified NK cells, CAR-NK cells, TCR-NK cells, combination therapies

Track: Next-Generation Therapies

Time: 16:15-17:15 (CET)

15.11.2022
Jefferies London Healthcare Conference 2022

Glycostem CEO Troels Jordansen is attending the Jefferies London Healthcare Conference from 15th to 16th Nov 2022 in London. The Jefferies London Healthcare Conference is the largest healthcare-dedicated conference in Europe.

14.11.2022
Inv€$tival Showcase

Glycostem CEO Troels Jordansen is attending Inv€$tival Showcase in London, UK on 14 Nov 2022. Inv€$tival is an international showcase of early, growth stage and public life science and health technology companies.

10.11.2022
SITC 37th Annual Meeting

Glycostem is going to present a poster at the SITC 37th Annual Meeting, held November 10-12, 2022,  in Boston, MA, USA.

Title: Cord blood CD34+ stem cells are efficiently transduced with anti-CD19-CAR and expanded and differentiated into viveNK™ Natural Killer cells which display selective cytotoxicity against B-cell leukemia

Abstract Number: 245

Presentation and Session Information*
Annual Meeting Regular Poster Abstract Presenter:    (245) Cord blood CD34+ stem cells are efficiently transduced with anti-CD19-CAR and expanded and differentiated into viveNK™ Natural Killer cells which display selective cytotoxicity against B-cell leukemia
    Poster Hall
    11/10/2022 - 11/11/2022, 9:00 am - 9:00 pm

Presented by: Monica Raimo

 

07.11.2022
Cell UK

Glycostem CDO Volker Huppert will be speaking at Cell Series UK conference on 7th - 8th November, 2022.